Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C3553409
Disease: CARDIOMYOPATHY, DILATED, 2B
CARDIOMYOPATHY, DILATED, 2B
0.700 GeneticVariation disease UNIPROT Homozygosity mapping and exome sequencing reveal GATAD1 mutation in autosomal recessive dilated cardiomyopathy. 21965549 2011
CUI: C3553409
Disease: CARDIOMYOPATHY, DILATED, 2B
CARDIOMYOPATHY, DILATED, 2B
0.700 Biomarker disease CTD_human
CUI: C3553409
Disease: CARDIOMYOPATHY, DILATED, 2B
CARDIOMYOPATHY, DILATED, 2B
0.700 Biomarker disease GENOMICS_ENGLAND
CUI: C3553409
Disease: CARDIOMYOPATHY, DILATED, 2B
CARDIOMYOPATHY, DILATED, 2B
0.700 CausalMutation disease CLINVAR
CUI: C0340427
Disease: Familial dilated cardiomyopathy
Familial dilated cardiomyopathy
0.300 GermlineCausalMutation disease ORPHANET Homozygosity mapping and exome sequencing reveal GATAD1 mutation in autosomal recessive dilated cardiomyopathy. 21965549 2011
CUI: C0878544
Disease: Cardiomyopathies
Cardiomyopathies
0.300 Biomarker group GENOMICS_ENGLAND
CUI: C0007193
Disease: Cardiomyopathy, Dilated
Cardiomyopathy, Dilated
0.100 Biomarker group HPO
Sensorineural Hearing Loss (disorder)
0.100 Biomarker disease HPO
CUI: C0018802
Disease: Congestive heart failure
Congestive heart failure
0.100 Biomarker disease HPO
CUI: C0023787
Disease: Lipodystrophy
Lipodystrophy
0.100 Biomarker disease HPO
CUI: C0026848
Disease: Myopathy
Myopathy
0.100 Biomarker group HPO
Creatine phosphokinase serum increased
0.100 Biomarker phenotype HPO
CUI: C0427515
Disease: Neutrophil abnormality
Neutrophil abnormality
0.100 Biomarker phenotype HPO
CUI: C0476403
Disease: Electromyogram abnormal
Electromyogram abnormal
0.100 Biomarker phenotype HPO
CUI: C1280433
Disease: Lipoatrophy
Lipoatrophy
0.100 Biomarker disease HPO
CUI: C4551675
Disease: Keratoderma, Palmoplantar
Keratoderma, Palmoplantar
0.100 Biomarker disease HPO
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.010 Biomarker group BEFREE To date, the relationship between GATAD1 amplification and glioma oncogenesis and malignancy is still unknown. 31286678 2019
CUI: C0017638
Disease: Glioma
Glioma
0.010 Biomarker disease BEFREE To date, the relationship between GATAD1 amplification and glioma oncogenesis and malignancy is still unknown. 31286678 2019
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.010 Biomarker group BEFREE The MTT and orthotopic tumor transplantation assays were used to identify the function of GATAD1 in glioma proliferation. cDNA microarray, ChIP qPCR, EMSA and 3C were used to screen the downstream mechanism of GATAD1 regulating glioma proliferation. 31286678 2019
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.010 Biomarker group BEFREE To date, the relationship between GATAD1 amplification and glioma oncogenesis and malignancy is still unknown. 31286678 2019
CUI: C0220630
Disease: Adult Liver Carcinoma
Adult Liver Carcinoma
0.010 AlteredExpression disease BEFREE Increased expression of GATA zinc finger domain containing 1 through gene amplification promotes liver cancer by directly inducing phosphatase of regenerating liver 3. 29266303 2018
Liver and Intrahepatic Biliary Tract Carcinoma
0.010 AlteredExpression disease BEFREE Increased expression of GATA zinc finger domain containing 1 through gene amplification promotes liver cancer by directly inducing phosphatase of regenerating liver 3. 29266303 2018
CUI: C0345904
Disease: Malignant neoplasm of liver
Malignant neoplasm of liver
0.010 AlteredExpression disease BEFREE Increased expression of GATA zinc finger domain containing 1 through gene amplification promotes liver cancer by directly inducing phosphatase of regenerating liver 3. 29266303 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.010 Biomarker disease BEFREE GATAD1 may serve as an independent poor prognostic factor for HCC patients.(Hepatology 2018;67:2302-2319). 29266303 2018
CUI: C0008497
Disease: Choriocarcinoma
Choriocarcinoma
0.010 AlteredExpression disease BEFREE The positive correlation between 3 [prime] methylation and GATAD1 expression was confirmed by treatment of choriocarcinoma JAR cells with DNMT inhibitor. 24462704 2014